Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Diagnostics underlines ultrasound future hopes with name change:

This article was originally published in Clinica

Executive Summary

Advanced Diagnostics (ADI), which develops products based on its diffractive ultrasound technology, has changed its name to Advanced Imaging Technologies (AIT). The Preston, Washington based-company believes that although diagnostic use of diffractive ultrasound will remain its key focus, it also has potential in instrument guidance and treatment planning. Diffractive ultrasound, which uses "through wave" transmission of sound to create detailed mages of soft tissue, has been used to create AIT's first product using the technology, the Avera breast imaging system. Avera provides real-time imaging without the need for radiation or painful compression, the company says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel